The stock's fall snapped a four-day winning streak.

Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Fintel reports that on October 8, 2024, Oppenheimer initiated coverage of Abbott Laboratories (NYSE:ABT) with a Outperform ...

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, ...

Somerset Trust Co lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.6% in the 3rd quarter, ...

MedTech portfolio is growing at a CAGR (compounded annual growing rate) of 11%-13%. The company’s non-MedTech operations are ...

Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

On Friday, Abbott Laboratories (ABT) stock saw a decline, ending the day at $112.43 which represents a decrease of $-0.30 or -0.27% from the prior close of $112.73. The stock opened at $112.93 and ...

Mattson Financial Services LLC cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 0.7% in the 3rd quarter, ...

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

Abbott Laboratories reported it achieved new major milestones to support the company's growing suite of pulsed field ablation (PFA) solutions in electrophysiology: early completion of enrollment in ...